WATSON 668 (Enalapril Maleate 2.5 mg)
Pill with imprint WATSON 668 is White, Round and has been identified as Enalapril Maleate 2.5 mg. It is supplied by Watson Pharmaceuticals.
Enalapril is used in the treatment of diabetic kidney disease; high blood pressure; heart failure; alport syndrome; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 668
Enalapril Maleate
- Imprint:
- WATSON 668
- Strength:
- 2.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0668
More about enalapril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 19 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
